rs2981582 is associated with FGFR2 expression in normal breast

Cancer Genetics and Cytogenetics

Volumn 197, Issue 2, 2010, Pages 193-194

  Sun, Chang ^a   Olopade, Olufunmilayo I ^a   Di Rienzo, Anna ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ACTIN; CCAAT ENHANCER BINDING PROTEIN BETA; FIBROBLAST GROWTH FACTOR RECEPTOR 2; TRANSCRIPTION FACTOR RUNX2;

BINDING AFFINITY; BREAST CANCER; DNA EXTRACTION; GENE EXPRESSION; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC VARIABILITY; GENOTYPE; HUMAN; LETTER; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; RISK FACTOR; RNA EXTRACTION; SINGLE NUCLEOTIDE POLYMORPHISM;

BREAST; BREAST NEOPLASMS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINKAGE DISEQUILIBRIUM; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 2; RETROSPECTIVE STUDIES;

EID: 77349115489     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.11.006     Document Type: Letter

References (17)

1. Antoniou A.C., Spurdle A.B., Sinilnikova O.M., Healey S., Pooley K.A., Schmutzler R.K., et al. Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82 (2008) 937-948
2. Easton D.F., Pooley K.A., Dunning A.M., Pharoah P.D., Thompson D., Ballinger D.G., et al. Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447 (2007) 1087-1093
3. Garcia-Closas M., Hall P., Nevanlinna H., Pooley K., Morrison J., Richesson D.A., et al. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics. PLoS Genet 4 (2008) e1000054
4. Gold B., Kirchhoff T., Stefanov S., Lautenberger J., Viale A., Garber J., et al. Genome-wide association study provides evidence for a breast cancer risk locus at 6q22.33. Proc Natl Acad Sci USA 105 (2008) 4340-4345
5. Huijts P.E., Vreeswijk M.P., Kroeze-Jansema K.H., Jacobi C.E., Seynaeve C., Krol-Warmerdam E.M., et al. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases. Breast Cancer Res 9 (2007) R78
6. Hunter D.J., Kraft P., Jacobs K.B., Cox D.G., Yeager M., Hankinson S.E., et al. A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat Genet 39 (2007) 870-874
7. Liang J., Chen P., Hu Z., Zhou X., Chen L., Li M., Wang Y., Tang J., Wang H., and Shen H. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women. Carcinogenesis 29 (2008) 2341-2346
8. McInerney N., Colleran G., Rowan A., Walther A., Barclay E., Spain S., Jones A.M., Tuohy S., Curran C., Miller N., Kerin M., Tomlinson I., and Sawyer E. Low penetrance breast cancer predisposition SNPs are site specific. Breast Cancer Res Treat 117 (2009) 151-159
9. Raskin L., Pinchev M., Arad C., Lejbkowicz F., Tamir A., Rennert H.S., Rennert G., and Gruber S.B. FGFR2 is a breast cancer susceptibility gene in Jewish and Arab Israeli populations. Cancer Epidemiol Biomarkers Prev 17 (2008) 1060-1065
10. Rebbeck T.R., DeMichele A., Tran T.V., Panossian S., Bunin G.R., Troxel A.B., and Strom B.L. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women. Carcinogenesis 30 (2009) 269-274
11. Stacey S.N., Manolescu A., Sulem P., Thorlacius S., Gudjonsson S.A., Jonsson G.F., et al. Common variants on chromosome 5p12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 40 (2008) 703-706
12. Udler M.S., Meyer K.B., Pooley K.A., Karlins E., Struewing J.P., Zhang J., et al. FGFR2 variants and breast cancer risk: fine-scale mapping using African American studies and analysis of chromatin conformation. Hum Mol Genet 18 (2009) 1692-1703
13. Meyer K.B., Maia A.T., O'Reilly M., Teschendorff A.E., Chin S.F., Caldas C., and Ponder B.A. Allele-specific up-regulation of FGFR2 increases susceptibility to breast cancer. PLoS Biol 6 (2008) e108
14. King J.A., Ofori-Acquah S.F., Stevens T., Al-Mehdi A.B., Fodstad O., and Jiang W.G. Activated leukocyte cell adhesion molecule in breast cancer: prognostic indicator. Breast Cancer Res 6 (2004) R478-R487
15. Rhodes D.R., and Chinnaiyan A.M. Integrative analysis of the cancer transcriptome. Nat Genet 37 Suppl (2005) S31-S37
16. Rhodes D.R., Kalyana-Sundaram S., Mahavisno V., Barrette T.R., Ghosh D., and Chinnaiyan A.M. Mining for regulatory programs in the cancer transcriptome. Nat Genet 37 (2005) 579-583
17. Liu W., Innocenti F., Wu M.H., Desai A.A., Dolan M.E., Cook Jr. E.H., and Ratain M.J. A functional common polymorphism in a Sp1 recognition site of the epidermal growth factor receptor gene promoter. Cancer Res 65 (2005) 46-53